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Abstract
BACKGROUND: Regional lymph node surgical management
is an integral part of cervical cancer therapy. In gynaecological
oncology, recent studies have confirmed the utility of the senti-
nel node concept in vulvar and cervical cancer. The method
of the marker’s administration is considered to play an impor-
tant role in sentinel node detection.
MATERIAL AND METHODS: 60 patients with cervical cancer
(stage IB–IIA) underwent SLN detection during radical abdom-
inal hysterectomy. The patients were randomly divided into two
groups: the first group of 30 patients with 0.5–1cm deep mar-
ker injection, the second with sub-epithelial marker injection.
Gamma-camera scanning, as well as hand-held probe detec-
tion was applied.
RESULTS: All hot nodes visualised on lymphoscintigraphy were
“hot” when using the hand-held gamma probe. Deep marker
injection revealed a sentinel node in 27 patients (90%) on both
sides, in 3 patients (10%) only on one side. Only 40 (67%) sen-
tinel nodes were blue-stained. Sub-epithelial marker adminis-
tration revealed a sentinel node on both sides in all 30 patients
(100%). In 28 patients (93.3%) the sentinel nodes were radio-
active and blue-stained, in one case not-blue stained on either
side, in one case blue stained only on one side.
CONCLUSIONS: The sentinel node detection rate in cervical
cancer is relatively high and depends on the applied technique.
The superficial administration of radiocolloid and the blue dye
into the cervix provides a higher sentinel node detection rate
than deep administration in cervical cancer patients.
Key words: sentinel node, cervical cancer,
lymphoscintigraphy
Introduction
The sentinel lymph node is defined as the first lymph node
along the lymphatic channel most likely to contain metastases
[1–4]. In order to detect this lymph node a marker substance
drained via lymphatic channels should be injected around the pri-
mary tumour: this can be done by using either a dye substance,
or a colloid radiotracer.
Studies in patients with breast cancer and melanoma have
shown that the sentinel lymph node concept is useful for predic-
ting regional lymph node metastases. Therefore, complete lym-
phadenectomy is not performed when the sentinel lymph node is
histologically free of metastasis. Although many authors present
encouraging results of sentinel node detection in cervical cancer
patients [5–12], there are still differences in the technique of marker
administration.
The aim of the study was to assess the influence of the depth
of marker administration on the sentinel node detection rate in
cervical cancer patients.
Material and methods
Patients
60 patients with early cervical cancer (stage IB–IIA) were in-
volved in the study. All patients underwent radical hysterectomy
and total pelvic lymphadenectomy. Informed consent was obtained
from each patient. We randomly divided patients according to the
depth of marker administration into two groups:
— the first group comprising 30 patients, where the 99mTc-labeled
radiocolloid was injected 5–10 mm deep into the cervix;
— the second group comprising 30 patients, where the 99mTc-
-labeled radiocolloid was injected in the sub-epithelial way.
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Pre-operative lymphoscintigraphy
Pre-operative lymphoscintigraphy was performed more than
18 hours before surgery utilising a single-head gammacamera
Diacam (Siemens, Erlangen, Germany) following injection around
the tumour 99mTc-labelled radiocolloid (Amersham, Amersham,
England) in a volume of 1.0 ml, dose range 35–70 MBq under
the guidance of a speculum-assisted view. The injection was applied
using an insulin syringe (22 G) in four sectors around the tumour.
Intra-operative lymphatic mapping
The injection of the radionuclide was repeated on the morning
of the procedure, 1 to 6 hours before surgery. The hand-held gam-
ma detector probe (Technical University, Gdansk, Poland), cali-
brated for a measuring range 130–150 keV, was used to detect
the sentinel node.
Blue dye was injected on the day of the operation after
the patient had undergone general anaesthesia. 4 ml of blue dye
was injected into four sectors around the cervix. In the 1st group,
blue dye was administered in the sub-epithelial way into the cervix.
In some cases after the blue dye injection a net of lymphatic ves-
sels was visible, which was considered to be proof of correct
marker administration. In the 2nd group, blue dye was adminis-
tered by 5 to 10 mm deep injection the same pattern as the radi-
ocolloid tracer administration.
During the operation the gamma detector probe was posi-
tioned along the lymph node regions to detect possible sentinel
nodes (SLNs). After the SLNs’ detection a conventional lym-
phadenectomy was performed.
As SLN was defined as a lymph node showing radioactivity
higher than 10% of that of the tumour site. The lymph node with
the strongest signal measurement was determined to be the sen-
tinel node, those following with a weaker signal were established
as post-sentinel nodes. Lymph nodes showing radioactivity iden-
tified with the use of the gamma detector probe, as well as blue-
-stained lymph nodes were removed. If there was more than one
blue dye node on one side, the sentinel node was determined to
be the blue dye node with the highest radioactive signal.
The SLN and post-SLN  were separately sent for pathologic
evaluation, fixed in buffered 4% formaldehyde solution, then stained
with hematoxillin/eosin (HE).
Results
The median age of  the 1st group cohort was 46.7 ± 12.3
years (range 27–76 years), the median age in the 2nd group
48.2 ± 12.8 years (range 28–76 years). The characteristics
of  patients in both groups are given in Table 1.
Pre-operative lymphoscintigraphy results
Pre-operative lymphoscintigraphy was performed before the
surgery in 15 patients in group 1 and in 15 in group 2. All 30 patients
had at least one sentinel node localized on lymphoscintigraphy.
In one case from the 1st group, a para-aortic sentinel node was locali-
zed. It was also a positive node on routine HE processing.
Intra-operative lymphatic mapping results
All nodes visualised on lymphoscintigraphy were “hot” when
using the hand-held gamma probe.
A total of 117 lymph nodes were identified as sentinel nodes
and 132 as post-sentinel nodes based on hand-held gamma probe
detection. 202 nodes were blue-stained: 134 (67%) in group 1
and 68 (33%) in group 2. The characteristics of sentinel nodes
identified in both groups are summarised in Table 2.
In the 1st group, in 27 patients the sentinel nodes were radio-
active on both sides. In 3 patients radioactivity was confirmed
only on one side. The sentinel nodes were blue-stained only in 40
(67%) patients from this group.
In the 2nd group, all the 30 patients’ sentinel nodes were radioac-
tive on both sides. In 28 (93.3%) patients the sentinel nodes showed
radiation and were blue-stained. In 1 case sentinel nodes were not-
-blue stained on either side, in one case only on one side. Altogether,
in 28 patients, 57 sentinel nodes became blue-dye visible.
No patients experienced anaphylaxis during the injection of ei-
ther blue dye or technetium-99 radiocolloid. Some patients com-
plained that the radionuclide injection was painful. The discomfort
was very brief and spontaneously disappeared after 1–2 minutes.
Table 1. Clinical patients and tumour characteristics in both groups
Characteristics Number of patients
Group 1st Group 2nd
(deep injection) (sub-epithelial injection)
Tumour FIGO stage
   IB1 19 18
   IB2 6 6
   IIA 5 6
Tumour size
   < 4 cm 22 23
   > 4 cm 8 7
Prior conisation
   no 28 28
   yes 2 2
Squamous 28 29
Adenocarcinoma 1 1
Adenosquamous 1 0
Table 2. Sentinel node blue/hot characteristics in analyzed groups
Hot Not hot
Group 1st Group 2nd Group 1st Group 2nd
(deep injection) (sub-epithelial injection) (deep injection) (sub-epithelial injection)
n = 30 n = 30 n = 30  n = 30
Blue-stained 40 57 3 0
Not blue-stained 17 3 0 0
Total 57 60 3 0
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allows more a efficient absorption of the tracer than a deeper in-
jection, when the marker is placed in the part of the cervix with
a relatively smaller density of lymphatic capillary vessels [15].
Conclusions
Superficial administration into the cervix of radioisotope-la-
belled colloid and blue dye has a higher sentinel node detection
rate than deep marker administration in cervical cancer patients.
Lymphoscintigraphy has a higher sentinel node detection rate
than blue dye injection, but the best results have been achieved
using these two methods together.
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Discussion
Regional lymph node status is being evaluated in all women
with cervical cancer undergoing surgery. Lymphadenectomy
of pelvic, parametrial, and para-aortic nodes causes increased
intra-operative and post-operative morbidity with bleeding, nerve
lesions, lymphoedema, and serocele formation. Lymphadenec-
tomy of tumour-negative nodes can potentially have a negative
influence on the immune system. More than 90% of the lymph
nodes resected are without nodal metastasis [5]. Therefore, ex-
tensive lymphadenectomy may be unnecessary in the majority
of patients. The most important factor in the sentinel procedure is
the standardisation of the technique. Some authors performed
sub-epithelial injections into the cervix [6–8], while others repor-
ted the 5–10 mm depth of the marker administrations [9–10]. There
is also a group of authors who do not mention anything about this
aspect [11–13].
In a discussion of the results given above, two questions
emerge:
— first — regarding the mutual relation of radiocolloid and blue-
-dye sentinel node identification techniques;
— second — regarding the influence of the injection technique
on the sensitivity of both methods.
Regarding the first issue, it seems that radiocolloid technique
is slightly superior to blue-dye method, but the best results are
achieved when these two techniques are applied simultaneously.
Malur and co-workers reported a cohort of 50 patients studied
with blue dye and/or radioactively labelled albumin techniques
[7]. The detection rate using blue dye, radioactively labelled albu-
min or both substances was respectively 55.5%, 76.2% and 90%.
The overall detection rate was 78%, sensitivity 83.3%, predictive
value 97.1%. The sensitivity and negative predictive value were
100% when both techniques were combined. Similar results were
reported by Verheijen et al. [14].
Regarding the second issue, we have compared two ways
of the marker administration. The use of the sub-epithelial meth-
od gave higher sentinel node detection rates, both in the radio-
colloid method and the blue dye method. The difference between
both techniques is visible especially with the blue dye application.
We achieved a  93% identification rate applying the sub-epithelial
injection technique and a  67% identification rate was achieved
with deep blue dye injection.
The authors are not aware of the comparative studies on
the influence of the injection site on the sensitivity of the lymphos-
cintigraphy/blue dye technique in cervical cancer.
The better results obtained with superficial marker adminis-
tration may be attributed to the anatomical structure of the cervi-
cal lymphatic system. Within the vaginal part of the cervix there is
a well developed net of capillary lymph vessels located just under
the cervical epithelium. The lymph from this part is drained to the
larger lymphatic vessels of the superficial layer of the cervical
muscular membrane. On the other hand the muscular membrane
has its own vessels net, which has its greatest density close to
the cervical mucosa. Therefore, superficial tracer administration
